Emerging therapies for colorectal cancer. - Wikidata - wikimedia - TriplyDB

Emerging therapies for colorectal cancer.

Emerging therapies for colorectal cancer.

http://www.wikidata.org/entity/Q36821373

about

Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells.

P2860

Q34977124-90337B89-4B1F-4EC2-BEC9-20E96005171C Q39925551-9DB6A74C-3DC7-4EF4-87BB-9E0AF8E82985

P2860

Emerging therapies for colorectal cancer.

http://www.wikidata.org/entity/Q36821373

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Emerging therapies for colorectal cancer.

@en

type

label

Emerging therapies for colorectal cancer.

@en

prefLabel

Emerging therapies for colorectal cancer.

@en

P1433

Q36821373-9A6D053D-3EE1-4761-8B12-57845071C2C1

P1476

Q36821373-D1FABE83-B91E-4AFE-9C79-4405D7620FEB

P2093

Q36821373-57828F1E-58F1-4EAD-AB10-45718532C079

Q36821373-C1C8DF83-21A5-4E7F-81A8-1421D91334C6

P2860

Q36821373-01BE3F6B-BCEC-4DC6-B5A7-D5128E446503

Q36821373-05B2359D-8F02-430D-9D67-E4A7AE7EB13A

Q36821373-075B8C4D-BF0B-4452-B385-EB887184FCB7

Q36821373-0B7FF331-4A17-4DAD-9FCE-25FC3AD1D084

Q36821373-0CA0BC72-A5B3-4041-B473-10FBCAFB4038

Q36821373-1069365E-55BF-4359-B61B-806EC9E4C486

Q36821373-1305BBB5-C554-4E6D-8C6E-4EFA0D1B5A19

Q36821373-18D28569-0892-4E4E-A32B-808163B4C3C6

Q36821373-21F31DBE-E625-40C3-B4FB-E08E89D0EA0B

Q36821373-256C0FFE-97AA-459A-97AF-A05AA8C572D8

P304

Q36821373-B33EA220-43EF-4374-B3C0-98079F2A9983

P31

Q36821373-2DFD9208-C1E7-485A-B259-098A726D29DF

P356

Q36821373-F1D7507F-073C-4EA9-B0E3-03425B86B185

P407

Q36821373-4422AC16-3508-4620-9D61-F7FB080C053A

P433

Q36821373-F0CE11A5-87FF-413F-9597-D37E60C6F2BE

P478

Q36821373-00BD5926-99CE-4289-AEBD-B0A486FB09AD

P577

Q36821373-D0F1A149-078D-43A9-B846-D8B0FB8305CB

P698

Q36821373-6D39F1A5-2BB8-4320-8F2C-D090ACF43342

P921

Q36821373-7F4C34C0-3C92-4631-ACDC-3E2922324E51

P356

13543784.16.6.867

P1433

Expert Opinion on Investigational Drugs

P1476

Emerging therapies for colorectal cancer.

@en

P2093

Aram F Hezel

http://www.w3.org/2001/XMLSchema#string

David P Ryan

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

Global cancer statistics, 2002

High frequency of mutations of the PIK3CA gene in human cancers

Lessons from hereditary colorectal cancer

Targeting the c-Met signaling pathway in cancer

Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils

PI 3-kinase p110beta: a new target for antithrombotic therapy

P304

867-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.16.6.867

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17501698

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer